Nrf2 activation has been shown to mitigate a number of pathologic mechanisms associated with AD, Parkinson’s disease, amyotrophic lateral sclerosis, Huntington’s disease, and multiple sclerosis (Wang et al. 2014). This evidence concerns the gene NFE2L2 and juvenile Huntington disease.